Paper4356983
Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s).
Gupta SL and 2 others. Biochem Biophys Res Commun, 1973. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s). Papers, record 4356983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4356983
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of protein synthesis directed by added viral and cellular messenger RNAs in extracts of interferon-treated Ehrlich ascites tumor cells. Location and dominance of the inhibitor(s).
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Ehrlich Tumor | Major topic |
| Interferons | Major topic |
| Neoplasm Proteins | Major topic |
| RNA, Messenger | Major topic |
| RNA, Viral | Major topic |
| Aminoacylation | |
| Animals | |
| Cell-Free System | |
| Cytosol | |
| Dialysis | |
| Dose-Response Relationship, Drug | |
| Encephalomyocarditis virus | |
| Kinetics | |
| L Cells | |
| Mice | |
| Protein Biosynthesis | |
| Reoviridae | |
| Ribosomes | |
| Spectrophotometry, Ultraviolet | |
| Time Factors | |
| Tritium | |
| Valine |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9623881 | The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. | Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9623881 | PubMed |
| 6620465 | Blockage of antiviral induction of interferon by homologous cell biochemical activity: effect of chicken embryo fibroblast mitotic cell cycle phases on Sindbis virus growth. | J Virol | 1983 | https://conductscience.org/library/papers/6620465 | PubMed |
| 4372392 | Effect of interferon upon the primary and secondary transcription of vesicular stomatitis and influenza viruses. | J Virol | 1974 | https://conductscience.org/library/papers/4372392 | PubMed |
| 4370654 | Mechanism of stimulation of murine type-C RNA tumor virus production by glucocorticoids: post-transcriptional effects. | J Virol | 1974 | https://conductscience.org/library/papers/4370654 | PubMed |
| 4140511 | The regulation of protein synthesis in mammalian cells VI. Soluble and polyribosome associated components in controlling in vitro polypeptide initiation in HeLa cells. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4140511 | PubMed |
| 909608 | Decreased initiation factor activity in mouse L cells treated with interferon. | Nature | 1977 | https://conductscience.org/library/papers/909608 | PubMed |
| 850310 | RNase activity in human interferon preparations. | J Virol | 1977 | https://conductscience.org/library/papers/850310 | PubMed |
| 291901 | Interferon action: induction of specific proteins in mouse and human cells by homologous interferons. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/291901 | PubMed |
| 284384 | Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284384 | PubMed |
| 283387 | Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/283387 | PubMed |
| 274708 | Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/274708 | PubMed |
| 219224 | Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA. | J Virol | 1979 | https://conductscience.org/library/papers/219224 | PubMed |
| 199154 | Antiviral activity of interferons. | Bacteriol Rev | 1977 | https://conductscience.org/library/papers/199154 | PubMed |
| 173882 | Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. | J Virol | 1975 | https://conductscience.org/library/papers/173882 | PubMed |
| 172661 | Block to multiplication of adenovirus serotype 2 in monkey cells. | J Virol | 1975 | https://conductscience.org/library/papers/172661 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4356983
GET https://conductscience.org/api/papers/v1/4356983/authors